Here’s what you should know:
1. President Trump made the remark as he signed a bill allowing terminally ill patients access to non-FDA approved therapies May 30.
2. Neither President Trump nor his administration would elaborate on what he meant, nor was his administration aware the announcement would be made.
3. White House Press Secretary Sarah Huckabee Sanders said there is policy in the works, but wouldn’t elaborate beyond that.
4. President Trump said, “We’re going to have some of the big drug companies in, in two weeks and they’re going to announce — because of what we did — they’re going to announce voluntary massive drops in prices, so that’s great. For the first time ever in this country, there will be a major drop in the cost of prescription drugs.”
5. President Trump has made several promises to lower drug costs in the past.
More articles on coding, billing and collections:
Senator’s proposal to lower healthcare costs touts ASC, physician-owned hospital use: 5 things to know
22 statistics on ASC case volume
31 updates for ASC leaders to know — May 2018
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
